FGF2 and cancer: Using public databases in GEO and TCGA, we found that the mRNA expression level of KLF5 positively correlated with that of FGF-BP1, which could bind to fibroblast growth factors such as FGF2, thus promoting the progression of cancer disease, including ESCC.